Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination.

Jarrah, Kawthar; Al Mahmasani, Layal; Atoui, Ali; Bou-Fakhredin, Rayan; Taher, Ali T

Jarrah, Kawthar; Al Mahmasani, Layal; Atoui, Ali; Bou-Fakhredin, Rayan; Taher, Ali T.

Jarrah K; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Al Mahmasani L; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Atoui A; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Bou-Fakhredin R; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Taher AT; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.

Blood Cells Mol Dis ; 93: 102641, 2022 03.

Article in English | MEDLINE | ID: covidwho-1588227

Subject(s)

BNT162 Vaccine/adverse effects; COVID-19/prevention & control; Hemoglobinuria, Paroxysmal/etiology; Adult; BNT162 Vaccine/therapeutic use; COVID-19/immunology; Complement Activation; Female; Hemoglobinuria, Paroxysmal/diagnosis; Hemoglobinuria, Paroxysmal/immunology; Hemolysis; Humans

Keywords

COVID-19; Paroxysmal nocturnal hemoglobinuria; Vaccine; mRNA

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / Hemoglobinuria, Paroxysmal Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Adult / Female / Humans Language: English Journal: Blood Cells Mol Dis Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: J.bcmd.2021.102641

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google